Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

abbvie deutschland gmbh & co. kg - verapamilo clorhidrato - verapamilo clorhidrato....180.000 miligramos / trandolapril....2.000 miligramos

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - capsules - see ingredients - each capsule contains trandolapril 2,0 mg verapamil hydrochloride 180,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - tablet - see ingredients - each tablet contains trandolapril 2,0 mg verapamil hydrochloride 180,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - tablet - see ingredients - each tablet contains trandolapril 4,0 mg verapamil hydrochloride 240,0 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

abbott laboratories de mexico, s.a. de c.v - clorhidrato de verapamilo - clorhidrato de verapamilo....180,00 mg / trandolapril....2,00 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية السختيان - sukhtian group - trandolapril 2 mg, verapamil hcl 180 mg - 2 mg, 180 mg

Namibia - English - Namibia Medicines Regulatory Council

abbott laboratories (pty) ltd - verapamil hcl, trandolapril - tablets - each film-coated tablet contains verapamil hydrochloride 180,0 mg, trandolapril 2,0 mg

Namibia - English - Namibia Medicines Regulatory Council

abbott laboratories (pty) ltd - verapamil hcl, trandolapril - tablets - each film-coated tablet contains verapamil hydrochloride 240,0 mg, trandolapril 4,0 mg

Canada - English - Health Canada

abbott laboratories, limited - terazosin (terazosin hydrochloride); terazosin (terazosin hydrochloride); terazosin (terazosin hydrochloride) - kit - 1mg; 2mg; 5mg - terazosin (terazosin hydrochloride) 1mg; terazosin (terazosin hydrochloride) 2mg; terazosin (terazosin hydrochloride) 5mg - alpha-adrenergic blocking agents

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - dofetilide (unii: r4z9x1n2nd) (dofetilide - unii:r4z9x1n2nd) - dofetilide 0.125 mg - tikosyn is indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [af/afl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. because tikosyn can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. in general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. recurrence is expected in some patients (see clinical studies ). tikosyn is indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. tikosyn has not been shown to be effective in patients with paroxysmal atrial fibrillation. tikosyn is contraindicated in patients with congenital or acquired long qt syndromes. tikosyn should not be used in patients with a baseline qt interval or qtc >440 msec (500 msec in patients wi